These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 5738734)
41. Interrupted quinestrol therapy for inhibition of ovulation: efficacy, duration, and side effects. Skerlavay M; Epstein JA Int J Fertil; 1967; 12(2):247-50. PubMed ID: 6033904 [No Abstract] [Full Text] [Related]
42. [Clinical experiences with two sequential oral contraceptive agents]. Larsson-Cohn U Lakartidningen; 1968 Dec; 65(51):5115-20 passim. PubMed ID: 4192633 [No Abstract] [Full Text] [Related]
43. Current perspectives on combination oral contraceptives. Smith MA; Youngkin EQ Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284 [TBL] [Abstract][Full Text] [Related]
44. Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesterone. Ferenczy A; Gelfand MM; van de Weijer PH; Rioux JE Climacteric; 2002 Mar; 5(1):26-35. PubMed ID: 11974556 [TBL] [Abstract][Full Text] [Related]
45. Systemic effects of a sequential regimen. Spain WT Int J Fertil; 1968; 13(4):431-5. PubMed ID: 5700402 [No Abstract] [Full Text] [Related]
46. Individual needs in oral contraception. Weisberg E Aust Fam Physician; 1980 Feb; Suppl():20-4. PubMed ID: 6444807 [TBL] [Abstract][Full Text] [Related]
47. Early symptoms and discontinuation among users of oral contraceptives in Sri Lanka. Basnayake S; Higgins JE; Miller PC; Rogers SM; Kelly SE Stud Fam Plann; 1984; 15(6 Pt 1):285-90. PubMed ID: 6393460 [TBL] [Abstract][Full Text] [Related]
48. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America. Moggia AV J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704 [TBL] [Abstract][Full Text] [Related]
49. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles. Woutersz TB J Reprod Med; 1981 Dec; 26(12):615-20. PubMed ID: 7033528 [TBL] [Abstract][Full Text] [Related]
54. [Experimental use of the new generation of Tri-Step contraceptive agents in 20 treated cases]. Spasojević M Med Arh; 1984; 38(2):83-4. PubMed ID: 6444082 [No Abstract] [Full Text] [Related]
55. Oral contraceptives, depression, and libido. Herzberg BN; Draper KC; Johnson AL; Nicol GC Br Med J; 1971 Aug; 3(5773):495-500. PubMed ID: 5565516 [TBL] [Abstract][Full Text] [Related]
56. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women. Paoletti AM; Orrù M; Lello S; Floris S; Ranuzzi F; Etzi R; Zedda P; Guerriero S; Fratta S; Sorge R; Mallarini G; Melis GB Contraception; 2004 Oct; 70(4):293-8. PubMed ID: 15451333 [TBL] [Abstract][Full Text] [Related]
57. Clinical experience with a low-dose contraceptive agent. European studies. Haspels AA J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703 [TBL] [Abstract][Full Text] [Related]
58. [The "sequential" method with a new estrogen-progesterone combination in ovulation control]. Bailo U; Finzi C Minerva Ginecol; 1968 Dec; 20(23):1885-7. PubMed ID: 5734793 [No Abstract] [Full Text] [Related]
59. Preliminary clinical study of Wy 3707 with ethinyl estradiol as an oral contraceptive. O'Roark HC; Lock FR; Smith Foushee JH; Burt RL Int J Fertil; 1966; 11(4):405-11. PubMed ID: 5970363 [No Abstract] [Full Text] [Related]